论文部分内容阅读
目的探讨氧气驱动雾化吸入盐酸氨溴索治疗小儿肺炎的临床治疗效果。方法选取医院2014年1月-2015年12月接收治疗并确诊的小儿肺炎患者84例,将其随机分为观察组和对照组各42例。对照组采用常规治疗,观察组在常规治疗的基础上给予氧气驱动雾化吸入盐酸氨溴索,观察2组患儿的治疗效果。结果观察组总有效率为85.7%高于对照组的47.6%,差异有统计学意义(P<0.05)。观察组患儿在经过治疗后2d后呼吸道症状较对照组明显缓解,差异有统计学意义(P<0.05)。结论氧气驱动雾化吸入盐酸氨溴索治疗相对于简单的常规治疗的临床效果要好,治疗和治愈的时间相对较短。
Objective To investigate the clinical effects of aerosol-driven inhalation of ambroxol hydrochloride in children with pneumonia. Methods Eighty-four children with pneumonia admitted to our hospital from January 2014 to December 2015 were selected and randomly divided into observation group (42 cases) and control group (42 cases). The control group was treated with conventional therapy. The observation group was given aerosol-driven inhalation of ambroxol hydrochloride on the basis of routine treatment, and the therapeutic effect was observed in both groups. Results The total effective rate in observation group was 85.7%, which was significantly higher than that in control group (47.6%) (P <0.05). The respiratory symptoms in observation group were significantly relieved 2 days after treatment, the difference was statistically significant (P <0.05). Conclusion Oxygen-driven inhalation of ambroxol hydrochloride has a better clinical effect than simple routine treatment, and the treatment and cure time is relatively short.